EE200200381A - Asendatud bensoüülguanidiinid, nende valmistamismeetod ja kasutamine ravimina või diagnostilise ainena ning neid sisaldav ravim - Google Patents

Asendatud bensoüülguanidiinid, nende valmistamismeetod ja kasutamine ravimina või diagnostilise ainena ning neid sisaldav ravim

Info

Publication number: EE200200381A
Authority: EE; Estonia
Prior art keywords: medicinal; preparation; products containing; diagnostic agents; substituted benzoylguanidines
Prior art date: 2000-01-19

Application number

EEP200200381A

Other languages

English (en)

Inventor

Weichert Andreas

Albus Udo

Jansen Hans-Willi

Kleemann Heinz-Werner

Lang Hans-Jochen

Original Assignee

Aventis Pharma Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-19

Filing date

2001-01-08

Publication date

2003-12-15

2001-01-08 Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh

2003-12-15 Publication of EE200200381A publication Critical patent/EE200200381A/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Surgery (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EEP200200381A 2000-01-19 2001-01-08 Asendatud bensoüülguanidiinid, nende valmistamismeetod ja kasutamine ravimina või diagnostilise ainena ning neid sisaldav ravim EE200200381A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10001879A DE10001879A1 (de)	2000-01-19	2000-01-19	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PCT/EP2001/000137 WO2001053256A1 (de)	2000-01-19	2001-01-08	Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament

Publications (1)

Publication Number	Publication Date
EE200200381A true EE200200381A (et)	2003-12-15

Family

ID=7627855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200381A EE200200381A (et)	2000-01-19	2001-01-08	Asendatud bensoüülguanidiinid, nende valmistamismeetod ja kasutamine ravimina või diagnostilise ainena ning neid sisaldav ravim

Country Status (26)

Country	Link
US (1)	US6703411B2 (et)
EP (1)	EP1259481B1 (et)
JP (1)	JP4880849B2 (et)
KR (1)	KR100726701B1 (et)
CN (1)	CN1184196C (et)
AR (1)	AR027237A1 (et)
AT (1)	ATE530518T1 (et)
AU (1)	AU780466B2 (et)
BR (1)	BR0107660A (et)
CA (1)	CA2397531A1 (et)
CZ (1)	CZ20022465A3 (et)
DE (1)	DE10001879A1 (et)
EE (1)	EE200200381A (et)
HR (1)	HRP20020592A2 (et)
HU (1)	HUP0204095A3 (et)
IL (1)	IL150740A0 (et)
MX (1)	MXPA02006431A (et)
NO (1)	NO20023383L (et)
NZ (1)	NZ520213A (et)
PL (1)	PL356589A1 (et)
RU (1)	RU2267486C2 (et)
SK (1)	SK10382002A3 (et)
TW (1)	TWI240718B (et)
WO (1)	WO2001053256A1 (et)
YU (1)	YU52202A (et)
ZA (1)	ZA200205696B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10204989A1 (de) *	2002-02-07	2003-08-21	Aventis Pharma Gmbh	Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US20050124666A1 (en)	2003-11-13	2005-06-09	Aventis Pharma Deutschland Gmbh	Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0556673B1 (de) *	1992-02-15	1997-09-17	Hoechst Aktiengesellschaft	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP2689058B2 (ja) *	1992-11-02	1997-12-10	新日本製鐵株式会社	塗装体の乾燥・焼付装置
DE4325822A1 (de) *	1993-07-31	1995-02-02	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) *	1993-08-27	1995-03-02	Hoechst Ag	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4430916A1 (de)	1994-08-31	1996-03-07	Merck Patent Gmbh	Alkyl-benzoylguanidin-Derivate
DE4430861A1 (de) *	1994-08-31	1996-03-07	Merck Patent Gmbh	Heterocyclyl-benzoylguanidine
DE19529612A1 (de)	1995-08-11	1997-02-13	Merck Patent Gmbh	Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate
DE19608161A1 (de) *	1996-03-04	1997-09-11	Hoechst Ag	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621319A1 (de) *	1996-05-28	1997-12-04	Hoechst Ag	Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19624178A1 (de)	1996-06-18	1998-01-08	Hoechst Ag	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

2000
- 2000-01-19 DE DE10001879A patent/DE10001879A1/de not_active Withdrawn
2001
- 2001-01-08 HU HU0204095A patent/HUP0204095A3/hu unknown
- 2001-01-08 AU AU23732/01A patent/AU780466B2/en not_active Ceased
- 2001-01-08 CZ CZ20022465A patent/CZ20022465A3/cs unknown
- 2001-01-08 RU RU2002122089/04A patent/RU2267486C2/ru not_active IP Right Cessation
- 2001-01-08 EE EEP200200381A patent/EE200200381A/et unknown
- 2001-01-08 NZ NZ520213A patent/NZ520213A/en unknown
- 2001-01-08 HR HR20020592A patent/HRP20020592A2/hr not_active Application Discontinuation
- 2001-01-08 EP EP01900139A patent/EP1259481B1/de not_active Expired - Lifetime
- 2001-01-08 SK SK1038-2002A patent/SK10382002A3/sk not_active Application Discontinuation
- 2001-01-08 JP JP2001553261A patent/JP4880849B2/ja not_active Expired - Fee Related
- 2001-01-08 CA CA002397531A patent/CA2397531A1/en not_active Abandoned
- 2001-01-08 PL PL01356589A patent/PL356589A1/xx not_active Application Discontinuation
- 2001-01-08 WO PCT/EP2001/000137 patent/WO2001053256A1/de not_active Ceased
- 2001-01-08 AT AT01900139T patent/ATE530518T1/de active
- 2001-01-08 YU YU52202A patent/YU52202A/sh unknown
- 2001-01-08 IL IL15074001A patent/IL150740A0/xx unknown
- 2001-01-08 CN CNB018038247A patent/CN1184196C/zh not_active Expired - Fee Related
- 2001-01-08 MX MXPA02006431A patent/MXPA02006431A/es active IP Right Grant
- 2001-01-08 KR KR1020027009256A patent/KR100726701B1/ko not_active Expired - Fee Related
- 2001-01-08 BR BR0107660-4A patent/BR0107660A/pt not_active IP Right Cessation
- 2001-01-17 US US09/760,670 patent/US6703411B2/en not_active Expired - Fee Related
- 2001-01-17 AR ARP010100207A patent/AR027237A1/es unknown
- 2001-01-17 TW TW090100987A patent/TWI240718B/zh not_active IP Right Cessation
2002
- 2002-07-12 NO NO20023383A patent/NO20023383L/no not_active Application Discontinuation
- 2002-07-17 ZA ZA200205696A patent/ZA200205696B/xx unknown

Also Published As

Publication number	Publication date
US20010016596A1 (en)	2001-08-23
WO2001053256A1 (de)	2001-07-26
DE10001879A1 (de)	2001-07-19
MXPA02006431A (es)	2002-11-29
ATE530518T1 (de)	2011-11-15
US6703411B2 (en)	2004-03-09
AU780466B2 (en)	2005-03-24
NO20023383D0 (no)	2002-07-12
BR0107660A (pt)	2002-11-19
EP1259481A1 (de)	2002-11-27
SK10382002A3 (sk)	2003-04-01
IL150740A0 (en)	2003-02-12
CN1184196C (zh)	2005-01-12
JP4880849B2 (ja)	2012-02-22
KR100726701B1 (ko)	2007-06-13
CN1395558A (zh)	2003-02-05
RU2267486C2 (ru)	2006-01-10
NZ520213A (en)	2004-08-27
HK1051853A1 (en)	2003-08-22
HRP20020592A2 (en)	2004-08-31
AR027237A1 (es)	2003-03-19
JP2003520267A (ja)	2003-07-02
KR20020073175A (ko)	2002-09-19
AU2373201A (en)	2001-07-31
HUP0204095A2 (hu)	2003-04-28
EP1259481B1 (de)	2011-10-26
ZA200205696B (en)	2003-11-26
HUP0204095A3 (en)	2005-05-30
TWI240718B (en)	2005-10-01
YU52202A (sh)	2006-01-16
CA2397531A1 (en)	2001-07-26
PL356589A1 (en)	2004-06-28
NO20023383L (no)	2002-09-03
RU2002122089A (ru)	2004-01-10
CZ20022465A3 (cs)	2002-10-16

Publication	Publication Date	Title
EE200200065A (et)	2003-04-15	3-aminopürasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena ning neid sisaldav farmatseutiline kompositsioon
EE200300080A (et)	2005-02-15	Polüarüülkarboksamiidühendid, nende valmistamine ja kasutamine lipiiditaset alandavate toimeainetena ning neid sisaldav farmatseutiline kompositsioon
EE05183B1 (et)	2009-06-15	Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
EE05170B1 (et)	2009-06-15	Asabitskloalkaanid kui CCR5 modulaatorid, neid sisaldavad farmatseutilised kompositsioonid ja kombinatsioonid ning nende meditsiiniline kasutamine
EE200300110A (et)	2005-04-15	Kaneelhappe asendatud guanidiidid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav ravim
EE04673B1 (et)	2006-08-15	Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid
EE05418B1 (et)	2011-06-15	Diarltskloalklderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
EE200000791A (et)	2002-02-15	Uudsed atsüülpseudopeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
EE05086B1 (et)	2008-10-15	Primidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus
EE200100037A (et)	2002-06-17	Bensotsüklohepteenid, nende valmistamise meetod, neid sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
EE04613B1 (et)	2006-04-17	Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
EE200200138A (et)	2003-06-16	Kinolüülpropüülpiperidiini derivaadid, nende valmistamine ja neid sisaldavad kompositsioonid
EE200000168A (et)	2001-04-16	Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE200300207A (et)	2003-08-15	Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
CY2011010I2 (el)	2014-04-09	Μακροκυκλικα αναλογα και μεθοδοι χρησης και παρασκευης τους
EE200300183A (et)	2003-06-16	Orto- ja meta-asendatud bisarüülühendid, nende kasutamine ja neid sisaldavad farmatseutilised preparaadid
EE9700141A (et)	1997-12-15	Piperasiinderivaadid, neid sisaldavad ravimid, nende kasutamine ja valmistamise meetod
EE200000430A (et)	2001-12-17	Triasolopüridasiini derivaadid, nende valmistamismeetod, neid sisaldav kompositsioon ning kasutamine ängistus- ja krambivastaste ravimite valmistamiseks
EE04717B1 (et)	2006-10-16	Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
EE200000587A (et)	2002-04-15	Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
EE200200292A (et)	2003-08-15	Asendatud norbornüülaminoderivaadid, nende valmistamine ja kasutamine ravimitena või diagnostilisteainetena ning neid sisaldav ravim
EE200100027A (et)	2002-06-17	Fosfororgaanilised ühendid, neid sisaldav farmatseutiline preparaat ja nende kasutamine
EE200000429A (et)	2001-12-17	Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
EE9800069A (et)	1998-10-15	Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised
EE9800264A (et)	1999-02-15	Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid